SOPHiA GENETICS Exec Chair Jurgi Camblong Sells Shares, Exercises Options

What Happened

• Jurgi Camblong, Executive Chairman and director of SOPHiA GENETICS SA (SOPH), reported multiple transactions on July 20–21, 2026. He sold a total of about 44,381 common shares in open-market transactions for aggregate proceeds of approximately $286,099. On July 20 he also exercised 4,581 options (reported as "M"), acquiring those shares at an exercise price of $3.16 for a cash cost of $14,476.
• The filings show both open-market sales and option exercises on the same dates. One derivative disposition line reports 4,581 shares at $0.00 (reported as a derivative disposal) while a separate open-market sale of 4,581 shares at a weighted average ~$6.17 for $28,244 was also recorded.

Key Details

• Transaction dates: July 20–21, 2026. Filing date: July 22, 2026 (timely within Form 4 rules).
• Sales (open market): 19,800 shares @ weighted avg $6.32 = $125,201 (range $6.30–$6.37, F2); 4,581 shares @ weighted avg $6.17 = $28,244 (range $6.10–$6.20, F3); 20,000 shares @ weighted avg $6.63 = $132,654 (range $6.60–$6.72, F4). Total proceeds ≈ $286,099.
• Exercise (M): 4,581 options exercised @ $3.16 = $14,476 (F5: options fully vested). A separate derivative disposition of 4,581 shares is reported at $0.00 on the same date.
• Holdings after transactions: Reporting person holds an aggregate 4,641,476 derivative share options across remaining tranches (F6).
• Notable footnotes: Some sales were made pursuant to a pre-established Rule 10b5-1 trading plan (F1). Prices for sales are reported as weighted averages with disclosed price ranges (F2–F4).
• Timeliness: Reported within the normal two-business-day window (no late filing flag).

Context

• "M" code = exercise or conversion of derivative securities (stock options). Here, Camblong exercised 4,581 options (paid $3.16/share) and reported related disposals/sales; the $0.00 derivative disposal line likely reflects an internal or net settlement reporting detail — the filing separately shows the actual open-market sale of those shares.
• Sales by officers are common and can be for many reasons (liquidity, tax obligations, planned trading). These filings are factual records of transactions and do not by themselves indicate company performance. Purchases or exercises that are retained are generally more informative of insider conviction than routine sales.